ISRG
ISRG's valuation is historically cheap, fundamentals are above averages and forward estimates point to improving growth and profitability.
ISRG vs Historical averages
| Metric | Current | AverageAverage | Relative |
|---|---|---|---|
| PE | 42x | 69x | 39% lower-39% |
| PE percentile | 2.6 | 50 | 95% lower-95% |
| EPS | $8.79 | $5.11 | 72% higher+72% |
| FCF | $3.2B | $1.4B | 129% higher+129% |
| Loading historical comparisons… | |||
ISRG’s earnings and cash flow are above their historical averages, while its earnings multiple is lower.
ISRG Forward outlook
| Metric | Outlook |
|---|---|
| Forward valuation | Improving |
| Forward earnings | Growth |
| Forward revenue | Growth |
| Forward profitability | Expanding |
| Analyst coverage | Moderate |
| Estimate dispersion | Tight |
ISRG’s outlook is generally improving, with growth expectations supporting the valuation case.
ISRG PE Valuation
This table applies ISRG's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.
ISRG Earnings Per Share
This chart tracks ISRG's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.
ISRG Quarterly Revenue
This chart tracks ISRG's quarterly revenue over time and shows how sales are changing from year to year.
ISRG Free Cash Flow
This chart tracks ISRG's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.
ISRG Total Shares
This chart tracks changes in ISRG's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.
ISRG Net Leverage
Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.
ISRG PE vs Healthcare Sector
This chart compares ISRG's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.
ISRG Weekly Price
This chart uses ISRG's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.
ISRG Weekly Moving Averages
This chart compares ISRG's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.
ISRG Yearly ROI
Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.
UNH
UNH's valuation appears fair, fundamentals are somewhat mixed, while forward estimates point to earnings growth and improving margins.
UNH vs Historical averages
| Metric | Current | AverageAverage | Relative |
|---|---|---|---|
| PE | 24x | 23x | 8% higher+8% |
| PE percentile | 71 | 50 | 42% higher+42% |
| EPS | $15.55 | $18.67 | 17% lower-17% |
| FCF | $23.6B | $21.7B | 9% higher+9% |
| Loading historical comparisons… | |||
UNH’s fundamentals are mixed relative to their historical averages, while its earnings multiple is higher.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Forward valuation | Improving |
| Forward earnings | Growth |
| Forward revenue | Stable |
| Forward profitability | Expanding |
| Analyst coverage | Moderate |
| Estimate dispersion | Moderate |
UNH’s outlook is generally improving, with growth expectations supporting the valuation case.
UNH PE Valuation
This table applies UNH's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.
UNH Earnings Per Share
This chart tracks UNH's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.
UNH Quarterly Revenue
This chart tracks UNH's quarterly revenue over time and shows how sales are changing from year to year.
UNH Free Cash Flow
This chart tracks UNH's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.
UNH Total Shares
This chart tracks changes in UNH's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.
UNH Net Leverage
Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.
UNH PE vs Healthcare Sector
This chart compares UNH's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.
UNH Weekly Price
This chart uses UNH's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.
UNH Weekly Moving Averages
This chart compares UNH's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.
UNH Yearly ROI
Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.